HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis B immunity in the pediatric liver transplant population.

AbstractPURPOSE OF REVIEW:
Hepatitis B virus (HBV) infection contributes significantly to vaccine-preventable disease related deaths, and insufficient HBV immunity may have unique implications for the pediatric liver transplant population. This article reviews the significance of HBV infection and the vaccination and screening measures needed to achieve adequate HBV immunity in these children.
RECENT FINDINGS:
HBV non-immunity among transplant candidates is higher than expected, even after appropriate completion of the vaccine series. Annual measurement of quantifiable HBV surface antibody in this vulnerable group should guide administration of booster and/or re-vaccination, improving immunoprotection from this potentially deadly hepatotropic virus. The liver plays a vital role in immune regulation; it induces immune tolerance and competence and both clears antigens from the circulation and generates liver-primed memory cells through antigen presentation via hepatic scavenger cells. Lymphocyte populations are depleted in patients with liver disease.
SUMMARY:
Immunity provided during early childhood against HBV infection is important to both pediatric liver transplant candidates and aging recipients. Appropriate vaccination and achievement of adequate immunity pre-transplant and post-transplant is critical. The field of pediatric transplantation is ripe for functional cellular and humoral immunity studies that examine factors which predict poor immune response to childhood vaccines, particularly HBV.
AuthorsShreena S Patel, Daniel H Leung
JournalCurrent opinion in pediatrics (Curr Opin Pediatr) Vol. 28 Issue 5 Pg. 653-8 (10 2016) ISSN: 1531-698X [Electronic] United States
PMID27367054 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Hepatitis B Vaccines
Topics
  • Antiviral Agents (therapeutic use)
  • Child
  • Hepatitis B (diagnosis, drug therapy, etiology, prevention & control)
  • Hepatitis B Vaccines (immunology)
  • Humans
  • Liver Transplantation
  • Pediatrics
  • Perioperative Care (methods)
  • Postoperative Complications (diagnosis, drug therapy, immunology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: